Literature DB >> 18544016

Fibrin: a versatile scaffold for tissue engineering applications.

Tamer A E Ahmed1, Emma V Dare, Max Hincke.   

Abstract

Tissue engineering combines cell and molecular biology with materials and mechanical engineering to replace damaged or diseased organs and tissues. Fibrin is a critical blood component responsible for hemostasis, which has been used extensively as a biopolymer scaffold in tissue engineering. In this review we summarize the latest developments in organ and tissue regeneration using fibrin as the scaffold material. Commercially available fibrinogen and thrombin are combined to form a fibrin hydrogel. The incorporation of bioactive peptides and growth factors via a heparin-binding delivery system improves the functionality of fibrin as a scaffold. New technologies such as inkjet printing and magnetically influenced self-assembly can alter the geometry of the fibrin structure into appropriate and predictable forms. Fibrin can be prepared from autologous plasma, and is available as glue or as engineered microbeads. Fibrin alone or in combination with other materials has been used as a biological scaffold for stem or primary cells to regenerate adipose tissue, bone, cardiac tissue, cartilage, liver, nervous tissue, ocular tissue, skin, tendons, and ligaments. Thus, fibrin is a versatile biopolymer, which shows a great potential in tissue regeneration and wound healing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544016     DOI: 10.1089/ten.teb.2007.0435

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  219 in total

1.  Hypoxic culture and insulin yield improvements to fibrin-based engineered tissue.

Authors:  Jason W Bjork; Lee A Meier; Sandra L Johnson; Zeeshan H Syedain; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2011-12-05       Impact factor: 3.845

2.  Enhanced adenovirus transduction of hMSCs using 3D hydrogel cell carriers.

Authors:  Alexander J Neumann; Josh Schroeder; Mauro Alini; Charles W Archer; Martin J Stoddart
Journal:  Mol Biotechnol       Date:  2013-02       Impact factor: 2.695

3.  Preparation of 3D fibrin scaffolds for stem cell culture applications.

Authors:  Kathleen Kolehmainen; Stephanie M Willerth
Journal:  J Vis Exp       Date:  2012-03-02       Impact factor: 1.355

Review 4.  Regenerative therapy after cancer: what are the risks?

Authors:  Vera S Donnenberg; Ludovic Zimmerlin; Joseph Peter Rubin; Albert D Donnenberg
Journal:  Tissue Eng Part B Rev       Date:  2010-11-02       Impact factor: 6.389

Review 5.  Application of cell and biomaterial-based tissue engineering methods in the treatment of cartilage, menisci and ligament injuries.

Authors:  Tomasz Trzeciak; Magdalena Richter; Wiktoria Suchorska; Ewelina Augustyniak; Michał Lach; Małgorzata Kaczmarek; Jacek Kaczmarczyk
Journal:  Int Orthop       Date:  2016-01-14       Impact factor: 3.075

Review 6.  Stem cells and nanomaterials.

Authors:  Marie-Claude Hofmann
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering.

Authors:  Hongzhi Zhou; Hockin H K Xu
Journal:  Biomaterials       Date:  2011-07-14       Impact factor: 12.479

8.  Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel.

Authors:  Ze-Wei Tao; Mohamed Mohamed; Matthew Hogan; Laura Gutierrez; Ravi K Birla
Journal:  J Tissue Eng Regen Med       Date:  2014-04-28       Impact factor: 3.963

9.  Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering.

Authors:  Jun Liu; Hockin H K Xu; Hongzhi Zhou; Michael D Weir; Qianming Chen; Carroll Ann Trotman
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

10.  Regeneration of uterine horns in rats using collagen scaffolds loaded with human embryonic stem cell-derived endometrium-like cells.

Authors:  Tianran Song; Xia Zhao; Haixiang Sun; Xin'an Li; Nacheng Lin; Lijun Ding; Jianwu Dai; Yali Hu
Journal:  Tissue Eng Part A       Date:  2014-09-19       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.